Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2008.121210v1, 2009; 10.1373/clinchem.2008.121210
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2008.121210v1
55/7/1389    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gronowski, A. M.
Right arrow Articles by Scott, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gronowski, A. M.
Right arrow Articles by Scott, M. G.

Received on November 21, 2008
Accepted on March 27, 2009

Endocrinology and Metabolism

False-Negative Results in Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Due to Excess hCG{beta} Core Fragment

Ann M. Gronowski 1*, Mark Cervinski 1, Ulf H. Stenman 2, Alison Woodworth 3, Lori Ashby 4, Mitchell G. Scott 1

1 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO
2 Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland
3 Department of Pathology, Vanderbilt University, Nashville, TN
4 Barnes-Jewish Hospital, St. Louis, MO

* To whom correspondence should be addressed. E-mail: gronowski{at}wustl.edu.

BACKGROUND: During pregnancy, hCG immunoreactivity in urine consists of intact hCG as well as a number of hCG variants including the core fragment of hCG{beta} (hCG{beta}cf). We identified 3 urine specimens with apparent false-negative results using the OSOM® hCG Combo Test (Genzyme Diagnostics) qualitative hCG device and sought to determine whether an excess of 1 of the fragments or variants might be the cause of the interference.

METHODS: We measured concentrations of hCG variants in the urine from 3 patients with apparent false-negative hCG results. Purified hCG variants were added to urines positive for hCG and tested using the OSOM, ICON® 25 hCG (Beckman Coulter), and hCG Combo SP® Brand (Cardinal Health) devices.

RESULTS: Dilution of these 3 urine samples resulted in positive results on the OSOM device. Quantification of hCG variants in each of the 3 patient urine specimens demonstrated that hCG{beta}cf occurred in molar excess of intact hCG. Addition of purified hCG{beta}cf to hCG-positive urines caused false-negative hCG results using the OSOM and ICON qualitative urine hCG devices.

CONCLUSIONS: Increased concentrations of hCG{beta}cf can cause false-negative results on the OSOM and ICON qualitative urine hCG devices.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. M. Gronowski, M. Powers, U. H. Stenman, L. Ashby, and M. G. Scott
False-Negative Results from Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Caused by Excess hCG{beta} Core Fragment Vary with Device Lot Number
Clin. Chem., October 1, 2009; 55(10): 1885 - 1886.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Association for Clinical Chemistry.